Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Porphyrias.

Raili Kauppinen1

  • 1Research Program in Molecular Medicine, Biomedicum-Helsinki, University of Helsinki, Finland. raili.kauppinen@hus.fi

Lancet (London, England)
|January 18, 2005
PubMed
Summary
This summary is machine-generated.

Porphyrias are rare inherited metabolic disorders affecting haem biosynthesis. Early diagnosis and genetic screening are crucial for managing symptoms and preventing attacks in affected individuals and families.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Guidelines for the management of acute porphyria: recommendations from the International Porphyria Network.

The Lancet. Haematology·2026
Same author

Long-term complications in acute porphyria.

Liver international : official journal of the International Association for the Study of the Liver·2024
Same author

Systematically testing human HMBS missense variants to reveal mechanism and pathogenic variation.

American journal of human genetics·2023
Same author

Systematically testing human HMBS missense variants to reveal mechanism and pathogenic variation.

bioRxiv : the preprint server for biology·2023
Same author

Pathogenesis of acute encephalopathy in acute hepatic porphyria.

Journal of neurology·2023
Same author

Effects of rifampicin on porphyrin metabolism in healthy volunteers.

Basic & clinical pharmacology & toxicology·2022

Area of Science:

  • Biochemistry
  • Genetics
  • Metabolic Disorders

Background:

  • Porphyrias are a group of rare inherited metabolic disorders.
  • They result from partial enzyme deficiencies in the haem biosynthesis pathway.
  • Clinical presentations include acute attacks and skin symptoms, often mimicking other diseases, leading to misdiagnosis.

Purpose of the Study:

  • To provide an overview of porphyrias, focusing on their diagnosis and management.
  • To highlight the importance of early detection and specific treatments for different porphyrias.
  • To emphasize the role of mutation screening in preventing disease progression and for family members.

Main Methods:

  • Biochemical analyses of porphyrins and precursors in blood, urine, or faeces for diagnosis.

Related Experiment Videos

  • Mutation screening during quiescent phases of the disease.
  • Clinical observation and patient history to identify symptoms and precipitating factors.

    • Main Results:

    • Biochemical analyses reliably detect porphyrins and precursors when porphyria is suspected.
    • Mutation screening is feasible and recommended for family members.
    • Specific treatments are required for individual porphyrias, and knowledge of precipitating factors aids management.

    Conclusions:

    • Porphyrias are rare but significant inherited metabolic disorders requiring specific diagnostic and treatment strategies.
    • Early diagnosis through biochemical testing and genetic screening is vital for effective management and prevention of complications.
    • Mutation screening in family members is recommended to identify at-risk individuals and facilitate early intervention.